Wyeth defends hormone replacement drug in court
303304
Wyeth on Wednesday faced   accusations that one of its hormone replacement therapy (HRT)   drugs caused breast cancer in a 67-year-old woman as one of the   thousands of trials the drug maker is facing over the treatment   got underway.
211428
Merck &amp; Co.'s chairman and chief executive Raymond Gilmartin yesterday defended his firm's handling of earlier health warnings about Vioxx and said he was &quot;stunned&quot; when he learned two weeks ago that a Merck clinical trial had confirmed the drug could cause strokes and heart attacks.
188021
GlaxoSmithKline Plc Tuesday defended  trials of AIDS/HIV drugs in children in care homes, saying  clinical studies involving children were legal and not unusual.
438884
Drugmaker Sanofi-Aventis , the  target of a lawsuit seeking class-action status filed on behalf  of shareholders, on Friday vowed to fight allegations it hid  the side-effects of its anti-obesity drug Acomplia.
89681
WASHINGTON -- The manufacturer of a hormone patch aimed at restoring women&#39;s lost libido told federal health advisers today that the therapy has not been linked to any serious safety problems and urged that approval not be delayed because of an unknown
533476
A lawsuit filed by the state and city of New York claims the drugmaker concealed the risks of the arthritis treatment Vioxx.
188330
Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney ...
25832
The American Heart Association defended the drug Vytorin, an expensive drug combination for cholesterol, which was shown last week to work no better than Zocor, a cheaper alternative.
346497
An FDA review of AstraZeneca Plc&#39;s (AZN.L: Quote, Profile, Research) (AZN.N: Quote, Profile, Research) Exanta questioned the experimental drug&#39;s
26459
Drugmaker Sanofi-Aventis , the target of a lawsuit seeking class-action status filed on behalf of shareholders, on Friday vowed to fight allegations it hid the side-effects of its anti-obesity drug Acomplia.
602739
WASHINGTON -- Local biotech powerhouses were comforted by yesterday's congressional testimony that urged federal regulators to take a cautious approach to approving generic versions of biologics, including mandatory human clinical trials.
362336
By Thomas Ginsberg, The Philadelphia Inquirer  Dec. 19--Wyeth Pharmaceuticals said today that the FDA has agreed to conduct a fast-track review of the company's new kidney cancer-fighting drug, Torisel.
761165
Wyeth (nyse: WYE - news - people ) is set to begin the second phase of a Philadelphia trial in which a plaintiff alleges heart valve injury from the use of the diet drug Pondimin, a drug the company once marketed.
85724
Wyeth WYE.N on Monday said it will  support proposed changes to a national settlement with former  users of its "fen-phen" diet drugs, allowing quicker  settlements for claims related to some of the less serious side  effects from the recalled appetite suppressants.
428114
Patients should not haphazardly stop taking the controversial diabetes drug Avandia, even though it has been linked to heart risks, an early critic of the drug said on Sunday.
711508
MADISON, NJ - Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration (news - web sites) granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney cancer.
299298
Drugmaker Wyeth said a court in Maryland has granted the company's motion to exclude some expert witnesses from testifying that exposure to thimerosal-containing vaccines can cause autism and rejected the compound's link to autism.